Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ArthroCare To Add 25-30 Sales Reps In Spine, ENT Units During 2001

This article was originally published in The Gray Sheet

Executive Summary

ArthroCare intends to expand its direct sales force by about 25-30 reps during 2001, primarily in the company's high-growth spinal surgery and ear, nose and throat (ENT) surgery businesses, as part of an expansion plan that includes replacing distributors in select geographic areas with a direct presence.

You may also be interested in...



Arthrocare Eyes Nucleoplasty System To Perc Up Sales, Monitors Inamed

Arthrocare is directing Wall Street's attention to potential growth opportunities for the firm's spinal surgery business as it monitors sales of its cosmetic surgery product line by distribution partner Inamed.

Adalvo Hails First European Launch Of Prolonged-Release Pregabalin

After the drug’s approval for use in neuropathic pain within the EU last December, Adalvo announced the analgesic’s first European launch in Germany.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014283

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel